Point72 Middle East Fze Trans Medics Group, Inc. Transaction History

Point72 Middle East Fze

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$36.74 - $81.08 $270,884 - $597,802	7,373 Added 67.1%	18,361 $1.45 Million
Q3 2023 Nov 14, 2023	BUY	$53.47 - $96.07 $587,528 - $1.06 Million	10,988 New	10,988 $601,000
Q1 2023 May 15, 2023	SELL	$53.63 - $82.33 $18,287 - $28,074	-341 Reduced 94.2%	21 $1,000
Q4 2022 Feb 14, 2023	BUY	$39.08 - $64.29 $14,146 - $23,272	362 New	362 $0

345

30.5M

671K

858K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.29B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.